Autolus Therapeutics (AUTL) Asset Utilization Ratio (2018 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Asset Utilization Ratio of 0.12 for Q4 2025, up 857.98% year-on-year from 0.01 in Q4 2024, and up 63.0% on a QoQ basis from 0.07 in Q3 2025.
Autolus Therapeutics (AUTL) Asset Utilization Ratio (2018 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Asset Utilization Ratio for 7 consecutive years, with 0.12 the latest figure, recorded in Q4 2025.
- Quarterly Asset Utilization Ratio rose 857.98% year-over-year to 0.12 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.12 (up 857.98% YoY) and the FY2025 annual result came in at 0.11, up 528.9% from the prior year.
- Asset Utilization Ratio climbed to 0.12 in Q4 2025 per AUTL's latest filing, from 0.07 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for AUTL reached as high as 0.12 in Q4 2025 and fell as low as 0.0 in Q2 2022.
- A 5-year average of 0.02 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 84.59% — and 2023, when it jumped 1255.17%.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2021, then jumped by 186.66% to 0.02 in 2022, then plunged by 73.55% to 0.0 in 2023, then surged by 189.51% to 0.01 in 2024, then jumped by 857.98% to 0.12 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.12, 0.07, and 0.04 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.12 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.00 |